子宫内膜异位症的生物标志物:挑战与机遇
本文综述子宫内膜异位症诊断生物标志物领域的挑战与机遇,强调在位子宫内膜非编码RNA作为潜在诊断标志物来源的重要性,并讨论验证候选诊断标志物所面临的困难。
要点
- 子宫内膜异位症诊断通常延迟8-10年,因青少年症状被误认为常见痛经。
- 综述探讨腹膜液、血液、尿液和子宫内膜活检中潜在诊断候选标志物。
- 强调在位子宫内膜组织及血液中非编码RNA表达水平作为诊断标志物来源的重要性。
核心结论
- 开发诊断生物标志物对于尽早诊断和治疗子宫内膜异位症妇女至关重要。
- 综述探讨了诊断生物标志物领域面临的机遇与挑战。
- 强调在位子宫内膜作为潜在诊断生物标志物来源的重要性。
研究设计与样本
- 综述类文章,检索范围未在原文中报告。
主要发现
- 子宫内膜异位症影响全球数百万妇女,症状包括痛经、慢性盆腔痛和不孕。
- 诊断通常延迟8-10年,因青少年和年轻女性症状被误认为常见月经绞痛。
- 年轻女孩中子宫内膜异位症发病率增加与初潮较早相关。
- 过去几年多篇综述列出了腹膜液、血液、尿液和子宫内膜活检中不同疾病分期和月经周期阶段的潜在诊断候选标志物。
- 通过观察组织及血液中非编码RNA表达水平,强调在位子宫内膜作为潜在诊断生物标志物来源的重要性。
关键数值与推荐
- 诊断延迟通常为8-10年。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文讨论了阻碍验证子宫内膜异位症候选诊断生物标志物的一些挑战,但未以局限性段落形式逐条列出具体局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endometriosis is a debilitating gynecologic disease affecting millions of women across the world, with symptoms including dysmenorrhea, chronic pelvic pain, and infertility. Theorized to stem from the phenomenon of retrograde menstruation, the diagnosis of endometriosis is typically delayed by 8-10 years owing to misinterpretation of symptoms as common menstrual cramps in adolescent girls and young women. With increased incidence of endometriosis in young girls correlated with earlier menarche, the development of diagnostic biomarkers is imperative for diagnosing and treating women afflicted with endometriosis as early as we can. In the past few years, multiple reviews highlighted the list of potential diagnostic candidates in peritoneal fluid, blood, urine, and endometrial biopsies from endometriosis patients in different stages of disease and menstrual cycle. In this review, we explore the opportunities and challenges facing the field of diagnostic biomarkers for endometriosis. We highlight the importance of eutopic endometrium as a source of potential diagnostic biomarkers by looking at the expression levels of noncoding RNA in tissue as well as in blood. Finally, we discuss some of the challenges that hinder our efforts in validating candidate diagnostic biomarkers for endometriosis.
引用
- Ahn SH, Singh V, Tayade C, et al. Biomarkers in endometriosis: challenges and opportunities. Fertil Steril. 2017. PMID: 28189296. doi:10.1016/j.fertnstert.2017.01.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。